Details
Category: Volume 07 Issue 10 October 2019
Hits: 1225

Title: Minimal Erythema Dose to Narrow Band Ultraviolet – B in a Group of Libyan Patients

Authors: Ali Mohamed Gargoom MD, Mustafa Nagmeddin Almukhtar MSc, Gamal Ahmed Duweb

 DOI: https://dx.doi.org/10.18535/jmscr/v7i10.14

Abstract

  

Background: Narrow-band ultraviolet B (NBUV-B) is now widely considered as the first choice phototherapy modality for most photo-responsive skin conditions. In most dermatology centers where phototherapy is performed, the starting dose of NBUV-B phototherapy is calculated as a proportion of the minimal erythema dose (MED). This is in order to maximize the therapeutic response, decreasing therapeutic duration and reducing the risk of burning.  Treatment with NBUV-B phototherapy  is usually given three times per week, with a typical course requiring 18-30 treatments for disease clearance.  Such treatment regimens require accurate assessment of the MED prior to commencing treatment in order to avoid overdoses or underdoes of NBUV-B.

Aim: The purpose of this study is to determine the MED of 311nm NBUV-B in a group of Libyan patients.

Methods: 150 patients with a various skin diseases who attending the phototherapy unit at Beer UstaMelad hospital of dermatology and venereology, Tripoli - Libya during an 8 months period were recruited for this prospective study.  The studied skin diseases include psoriasis, vitiligo, atopic dermatitis and others. All patients were classified into skin types using the questionnaire of Fitzpatrick. Irradiation with 311nm NBUV-B was performed over the right forearm by using a MED tester device (Dermalight® 80 ) then the results of the test were recorded 24 hours later.

Results: Among the studied patients; 82(54.7%) patients were females and 68(45.3%) patients were males. Their age ranged between 10 - 60 years while 30% of the included group were in the  age group of  31- 40 years. The patients were diagnosed on clinical grounds to have the following conditions; vitiligo 65(43.3%) patients, psoriasis 61(40.7%) patients,  eczema   8(5.3%)   patients,  pruritus  6(4%)  patients  and  alopecia  areata  and lichen planus  5(3.3%) patients each . According to Fitzpatrick's classification, the skin phototypes of the included series were; 15(10%) patients of skin type III, 118 (78.7%) patients of  skin type IV  and 17(11.3%)  patients of skin type V. The minimal required dose to produce an erythema for NBUV-B among the recruited patients was ranged between 300 mJ/cm2  to 750 mJ/cm2 with a mean dose of 484.7±82.2 mJ/cm2.

Conclusions: The mean MED to 311nm NBUV-B in Libyan patients was around 500 mJ/cm2, and this  can be used to decide the initial dose and treatment regimen of phototherapy for different skin diseases.

Phototherapy, Narrowband, Erythema, Minimal, Dose 

References

  1. Sally H. Ibbotson. A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy. Front Med (Lausanne). 2018; 5: 184.
  2. Heckman, C.J., Chandler, R., Kloss, J.D., Benson, A., Rooney, D., Munshi, T., Darlow, S.D., Perlis, C., Manne, S.L., Oslin, D.W. Minimal Erythema Dose (MED) Testing. Vis. Exp. (75), e50175, doi:10.3791/50175 (2013).
  3. Pai GS, Vinod V, Krishna V. Med estimation for narrow band UV-B on type IV and type V skin in India. Indian J Dermatol Venereol Leprol. 2002; 68: 140- 141
  4. TejasVvi T, Sharma VK, Kaur J. Determination of minmal erythema dose for narrow band UVB radiation in north Indian patients: Comparison of visual and derma spectrometer® readings.  Indian J DermatolVenereolLeprol.  2007;73:97-99.
  5. Sachdeva S. Fitzpatrick s kin typing: Applications in dermatology. Indian J Dermatol Venereol Leprol 2009;75:93-6.
  6. Gilchrest BA, Stoff JS and Soter NA (1982): Chronologic aging alters the response to ultraviolet-induced inflammation in human skin. J Invest Dermatol; 79(1):11-5.
  7. Cox NH, Diffey BL, Farr PM.The relationship between chronological age and the erythemal response to ultraviolet B radiation. Br J Dermatol 1992; 126: 315–19.
  8. Brown TT, Quain RD, Troxel AB and Gelfand JM (2006): The epidemiology of sunburn in the US population in 2003. J Am Acad Dermatol; 55(4):577-83.
  9. Lock-Andersen J, Drzewiecki KT and Wulf HC (1999): Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm Venereol; 79(1):74-80.
  10. Cox NH, Farr PM, Diffey BL. A comparison of the dose– response relationship for psoralen-UVA erythema and UVB erythema. Arch Dermatol 1989; 125: 1653–7.
  11. Gordon PM, Saunders PJ, Diffey BL et al. Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1998; 139: 811–14.
  12. Leslie KS, Lodge E, Garioch JJ. A comparison of narrowband (TL-01) UVB-induced erythemal response at different body sites. Clin Exp Dermatol 2005; 30:337–9.
  13. Youn JI, Oh JK, Kim BK, Suh DH, Chung JH, Oh SJ, et al. Relationship between skin photo type and MED in Korean brown skin. Photodermatol Photoimmunol Photomed1997;13:208-11.
  14. Wee LK, Chong TK, Quee DK. Assessment of skin types, skin colours and cutaneous responses to ultraviolet radiation in an Asian population. Photodermatol Photoimmunol Photomed 1997;13:169-72.
  15. Alora MB, Taylor CR. Narrow-band (311 nm) UVB phototherapy: an audit of the first years' experience at the Massachusetts General Hospital. Photodermatol Photoimmunol Photomed 1997; 13:82–4.
  16. Venkataram M N, Haitham Al Amiri, Correlating skin phototype and minimum erythema dose in Arab skin. International Journal of Dermatology 2003, 42.191–192.
  17. Chin Yi, Tsai Tsen. The minimal erythema dose of 311-nm Narrow-band UVB in Taiwanese. 2002; From department of dermatology, National Taiwan  University Hospital.

Corresponding Author

Ali Mohamed Gargoom

Dermatology Department, Faculty of Medicine, Benghazi University, Benghazi Libya